Andrew Johnson, CEO of Yardstik – Interview Series

Andrew Johnson, CEO of Yardstik, is an experienced technology executive with a background in scaling high-growth software companies, building go-to-market organizations, and driving enterprise revenue. He joined Yardstik as Chief Operating Officer in 2022 before being promoted to CEO in October 2024. Previously, Johnson served as Chief Revenue Officer at Branch, where he helped guide…

Read More

MSK and OpenEvidence Announce Two-Way Oncology AI Integration

Memorial Sloan Kettering Cancer Center and OpenEvidence announced a partnership on September 16, 2026, that pairs the integration of OpenEvidence’s medical AI platform into MSK’s Epic electronic health record workflow with the integration of OncoKB, MSK’s precision oncology knowledge base, directly into OpenEvidence for broader use by providers outside MSK. How the Integration Works at…

Read More

Rune Raises $40M to Turn Stranded Solar Power Into AI Compute

Rune has raised $40 million in Series A funding as the energy infrastructure startup looks to address one of artificial intelligence’s increasingly significant constraints: finding enough electricity to power rapidly expanding compute infrastructure. The round was led by Spark Capital, with participation from Union Square Ventures, Lowercarbon Capital, Activate Capital, Committed Capital, Timeless Partners, and…

Read More

Denise Ruffner, VP Business Development and Commercial Operations Worldwide, Haiqu – Interview Series

Denise Ruffner, VP Business Development and Commercial Operations Worldwide at Haiqu, is a seasoned technology executive with extensive experience commercializing quantum computing and other emerging technologies. At Haiqu, she leads business development and worldwide expansion, building on previous leadership roles including Chief Business Officer at Atom Computing and Cambridge Quantum Computing, Vice President of Business…

Read More

Novo Nordisk Taps Anthropic’s Claude to Speed Drug Discovery

Novo Nordisk and Anthropic announced a collaboration on September 16, 2026, under which the drugmaker will use Anthropic’s frontier AI models and test the Claude Science workbench in specific research and development workflows, with the stated goal of accelerating the discovery and development of new medicines. Collaboration Scope and Governance In the announcement, datelined Bagsværd,…

Read More
Back To Top